Pharma’s getting left with the bill

Did you know last year big Pharma companies Merck, Eli Lilly, Ranbaxy, Pfizer, Johnson & Johnson and Glaxo Smith Kline paid $13 Billion in penalties to different regulatory authorities directly related to counterfeit drugs?

 

The 7th Pharma Anti-Counterfeiting and Brand Protection Summit is being held this March 26-28 in Philadelphia, PA. One of the primary focuses of this event is it’s networking and solution showcasing opportunities, which allow solution providers exclusive access to event industry decision makers looking to solve current market issues.

 

Download Sponsorship Prospectus

Request a Copy: Max.Miller@iqpc.com

 

Notable speakers at this year’s event include:

 

·       Charles Forsaith, Director, Supply Chain Security, Pfizer

·       David G. Howell, Director - Brand Protection, Vorys, Sater, Seymour and Pease LLP

·       Milton A. Tyrrell, Supervisory Special Agent (Unit Chief), Drug Enforcement Administration

·       Gregory Bylo, VP, Healthcare, GS1 US

·       M. David Malenfant, Executive Vice President, Biotech Supply Management Alliance

·       And more!

 

For more information on sponsorship opportunities at this year’s event contact Max Miller

 

Max Miller | Max.Miller@iqpc.com | 001-212-885-2753

Picture of the Logo of the Pharma Anti-Counterfeiting and Brand Protection Summit
Conference Logo